GlassScriptPhysician profile
Trena Rios
NPI 1326549809
$2,607.37
in general payments reported to CMS, 2019-2025
23 companies · $344 in 2025
The $344 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $179 · 2022: $1,041 · 2023: $254 · 2024: $789 · 2025: $344.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,386.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $437.37 | 2022-2024 | Austedo Xr |
| Amgen INC. | $291.03 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $242.81 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $224.11 | 2024 | Lokelma, Airsupra |
| Neurocrine Biosciences, INC. | $139.57 | 2025 | |
| Janssen Scientific Affairs, LLC | $121.41 | 2024 | Tremfya |
| Medtronic, INC. | $120.37 | 2023 | Intellis Adaptivestim |
| Insulet Corporation | $114.46 | 2025 | Omnipod |
| Regeneron Healthcare Solutions, INC. | $109.65 | 2023 | Libtayo |
| Boston Scientific Corporation | $108.12 | 2024 | Watchman Flx |
| Sanofi-Aventis U.S. LLC | $106.13 | 2024 | |
| Scpharmaceuticals INC. | $106.00 | 2024 | |
| Phathom Pharmaceuticals, INC. | $89.54 | 2025 | Voquezna |
| Upsher-Smith Laboratories LLC | $71.59 | 2021-2022 | |
| Nevro Corp. | $57.75 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $55.29 | 2021-2022 | |
| Abbvie INC. | $51.80 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $44.19 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $41.29 | 2022 | |
| Avanos Medical | $24.39 | 2023 | Generator |
| Lundbeck LLC | $21.37 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.55 | 2022 | |
| Merck Sharp & Dohme LLC | $13.58 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trena Rios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.